Technology News and Research

RSS

Study pinpoints brain networks behind speech planning

A new study has identified a brain circuit that is active while we plan our spoken replies during conversation.

5 Jan 2022

Study: Many people prefer to speak about negative experiences with a virtual reality avatar

If you find opening up to a therapist too daunting, new research shows you're not alone – and you might soon have a new option.

5 Jan 2022

Oral bacteria-based SARS-CoV-2 vaccine platform

In a new study, researchers engineered the bacterial strain, Salmonella, to express differently-sized antigens to serve as vaccine platforms.

5 Jan 2022

Understanding and overcoming the challenges of chemical synthesis at a global Contract Research Organisation

In this interview, News-Medical talks to Andrew Kennedy and Jono West from Sai Life Sciences, about the work they do and how they utilise Radleys equipment in order to understand and overcome chemical synthesis challenges.

From Radleys 5 Jan 2022

Unique nanoparticle can deliver genome editing technology to endothelial cells

The lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to endothelial cells, which are cells that line blood vessel walls.

4 Jan 2022

Researchers develop acoustic virtual reality-based archery game for blind people

Researchers at the IIT-Istituto Italiano di Tecnologia developed an acoustic virtual reality-based archery game, enabling blind people to experience for the first time this type of technology, which is typically focused on vision.

4 Jan 2022

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

Empire Discovery Institute entered into a five-year collaborative research partnership with global pharmaceutical company Novo Nordisk A/S to launch LeapRx, a new initiative where EDI and Novo Nordisk will co-invest, incubate and accelerate innovative drug discovery and development projects from its academic partners.

4 Jan 2022

Oxford researchers demonstrate the feasibility of increasing the speed and volume of vaccine production

The University of Oxford's vaccine manufacturing research team has today published a pre-print paper demonstrating the feasibility of a step change in the speed and volume of production of adenovirus-vectored vaccines against new virus variants or other future pandemics.

4 Jan 2022

Study offers more insight into respiratory event-related sleep fragmentation and OSA severity

Obstructive sleep apnea is a common breathing disorder causing excessive daytime sleepiness and increasing the risk for cardiovascular disease, hypertension, and stroke.

4 Jan 2022

Sino Biological Establishes New Location in Houston, Texas

Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on ChiNext (SZSE: 301047), provides biological research reagents and related technical contract research services, is pleased to announce its physical geographic expansion, adding a new location in Houston, Texas.

From Sino Biological Inc. 4 Jan 2022

The brains of infants with autism do not tune in with motherese speech

Motherese is a form of simplified, exaggerated melodic speech that parents use to communicate with newborns and young toddlers.

3 Jan 2022

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening.

3 Jan 2022

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

Researchers combine SARS-CoV-2 spike vaccination with single-cell B-cell receptor sequencing technology to discover neutralizing antibody candidates.

3 Jan 2022

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

Patients with morbid obesity experienced improvement in their quality of life and distinctly fewer episodes of overeating after ten weeks with a new treatment method developed at NTNU.

3 Jan 2022

New MXene-based wearable sensor may help athletes with real-time performance measurements

Ultrathin nanomaterials, known as MXenes, are poised to make it easier to monitor a person's well-being by analyzing their perspiration.

3 Jan 2022

Engineer receives $2.1 million grant to test a treatment strategy for children with cerebral palsy

Mechanical engineer and inventor Zach Lerner, assistant professor in Northern Arizona University's Department of Mechanical Engineering, has been awarded $2.1 million by the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health & Human Development.

3 Jan 2022

New technique combines bioprinting with cryopreservation to construct frozen structures

A new technique takes bioprinting - in which an ink of cells is printed, layer by layer, to form a structure - to a whole new, and icy level. Investigators from the Zhang lab at Brigham and Women's Hospital have developed a technology that they term "cryobioprinting," a method that uses a bioink embedded with cells to print frozen, complex structures that can be easily stored for later use.

31 Dec 2021

Study uses metabolomics to discriminate drug-induced liver injury phenotypes

Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.

30 Dec 2021

Intestinal organoids used to explain why bats infected with viruses do not succumb to diseases

Experiments attempting to explain why bats can be infected with many viruses at a time without succumbing to diseases such as COVID-19 - knowledge that could help us to reduce the threat to humans of infectious disease - have struggled until now with the fact that live wild bats make poor research subjects.

30 Dec 2021

Human iPSC-derived fallopian tube organoids reveal the origins of common ovarian cancer

Stem cell scientists have revealed the origins of a common ovarian cancer by modeling fallopian tube tissues, allowing them to characterize how a genetic mutation puts women at high risk for this cancer.

29 Dec 2021

Technology News and Research

Study pinpoints brain networks behind speech planning

Study: Many people prefer to speak about negative experiences with a virtual reality avatar

Oral bacteria-based SARS-CoV-2 vaccine platform

Understanding and overcoming the challenges of chemical synthesis at a global Contract Research Organisation

Unique nanoparticle can deliver genome editing technology to endothelial cells

Researchers develop acoustic virtual reality-based archery game for blind people

Empire Discovery Institute collaborates with Novo Nordisk to launch new drug discovery initiative

Oxford researchers demonstrate the feasibility of increasing the speed and volume of vaccine production

Study offers more insight into respiratory event-related sleep fragmentation and OSA severity

Sino Biological Establishes New Location in Houston, Texas

The brains of infants with autism do not tune in with motherese speech

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

New MXene-based wearable sensor may help athletes with real-time performance measurements

Engineer receives $2.1 million grant to test a treatment strategy for children with cerebral palsy

New technique combines bioprinting with cryopreservation to construct frozen structures

Study uses metabolomics to discriminate drug-induced liver injury phenotypes

Intestinal organoids used to explain why bats infected with viruses do not succumb to diseases

Human iPSC-derived fallopian tube organoids reveal the origins of common ovarian cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News